Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4354 Neoplasms 3056 Prostatic Neoplasms 1904 Colorectal Neoplasms 1739 Lung Neoplasms 1555 Carcinoma, Non-Small-Cell Lung 1270 Pancreatic Neoplasms 981 Leukemia, Myeloid, Acute 952 Multiple Myeloma 951 Lymphoma 912 Head and Neck Neoplasms 894 Leukemia 852 Precursor Cell Lymphoblastic Leukemia-Lymphoma 833 Neoplasm Metastasis 793 Colonic Neoplasms 785 Carcinoma, Hepatocellular 762 Ovarian Neoplasms 757 Melanoma 752 Stomach Neoplasms 742 Rectal Neoplasms 701 Brain Neoplasms 696 Lymphoma, Non-Hodgkin 663 Leukemia, Lymphocytic, Chronic, B-Cell 618 Uterine Cervical Neoplasms 607 Lymphoma, Follicular 559 Glioblastoma 541 Recurrence 539 Hodgkin Disease 532 Esophageal Neoplasms 527 Myelodysplastic Syndromes 508

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × ENT Cancer × Clear all

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡